Tigit

Gilead stops phase 3 TIGIT trial, doubling down on other studies and pumping $320M into partner Arcus
Fierce Biotech
Tue, 01/30/24 - 10:34 am
Gilead Sciences
Arcus Biosciences
Tigit
lung cancer
clinical trials
Roche racks up phase 3 TIGIT win, but trial design leaves doubts
Fierce Biotech
Wed, 01/17/24 - 09:33 am
Roche
Tigit
immuno-oncology
tiragolumab
clinical trials
Roche posts interim TIGIT overall survival data after 'inadvertent disclosure,' sending stocks up
Fierce Biotech
Wed, 08/23/23 - 10:10 am
Roche
Tigit
clinical trials
lung cancer
non-small cell lung cancer
tiragolumab
Roche's closely watched immunotherapy fails key study in tough-to-treat lung cancer
BioPharma Dive
Wed, 03/30/22 - 10:54 am
Roche
tiragolumab
clinical trials
Tigit
advanced small cell lung cancer
A year of TIGIT (and Alzheimer’s) for Roche
EP Vantage
Thu, 02/3/22 - 10:53 am
Roche
Tigit
tiragolumab
Alzheimer's disease
AACR 2020 preview – no Tigit, but plenty of novel mechanisms
EP Vantage
Wed, 04/22/20 - 10:56 am
AACR
virtual meetings
conferences
Tigit
OX40
Roche move endorses Iteos’s Tigit widget
EP Vantage
Tue, 03/3/20 - 10:52 am
Roche
Tigit
tiragolumab
Arcus Biosciences
iTeos Therapeutics
Roche’s next immuno-oncology combo is a big bet on Tigit
EP Vantage
Fri, 01/31/20 - 10:47 am
Roche
immuno-oncology
Tigit